Keyphrases
Acute Effects
59%
Acute Renal Failure
27%
Angiotensin II (Ang II)
20%
Antinatriuresis
27%
ARMAX
22%
Baroreflex
27%
Cardiac Output
20%
Cardiopulmonary Bypass
44%
Central Hemodynamics
55%
Chronic Obstructive Pulmonary Disease
33%
Common Bile Duct Ligation
27%
Confidence Interval
18%
Congestive Heart Failure
27%
Conscious Rat
27%
Diethylstilbestrol
27%
Efferent Ducts
27%
Extraction Effect
27%
Glomerular Filtration Rate
42%
Glucagon-like
94%
Healthy Individuals
59%
Heart Rate
26%
Kidney Function
31%
L-NAME
23%
Lipopolysaccharide-induced
27%
Liraglutide
27%
Liver
27%
Loop of Henle
55%
Losartan
27%
Nephropathy
27%
Nitric Oxide Synthase Inhibition
27%
Octreotide
27%
Oxygenation Index
22%
Phosphodiesterase 3 (PDE3)
27%
Phosphodiesterase-4 (PDE4)
27%
Pulmonary Perfusion
55%
Pulmonary Protection
27%
Randomized Clinical Trial
55%
Renal Disease
27%
Renal Hemodynamics
61%
Renal Plasma Flow
26%
Renin-angiotensin-aldosterone System
27%
Short-term Effects
27%
Sodium Retention
37%
Statistical Analysis Plan
27%
Thick Ascending Limb
31%
Thick Ascending Limb of Henle
30%
Type 2 Diabetes Mellitus (T2DM)
27%
Type 2 Diabetic Patients
38%
Vasopressin
33%
Vasopressin V2 Receptor
27%
Medicine and Dentistry
Acute Kidney Injury
27%
Angiotensin II
18%
Aquaporin 2
29%
Aquaporin 9
27%
Bile Duct Ligation
27%
Cardiopulmonary Bypass
55%
Chronic Obstructive Pulmonary Disease
55%
Common Bile Duct
30%
Glomerular Filtration Rate
46%
Glucagon Like Peptide 1
83%
Heart Output
20%
Heart Surgery
18%
Henle Loop
27%
Histidine
23%
Infusion
20%
Kidney Blood Flow
100%
Kidney Function
38%
Kidney Plasma Flow
26%
Limb
29%
Lipopolysaccharide
27%
Liraglutide
27%
Maturity Onset Diabetes of the Young
27%
Nephropathy
27%
Nitric Oxide Synthase
27%
Nociceptin
27%
Octreotide
27%
Patient with Type 2 Diabetes
38%
Phosphodiesterase III
27%
Pulmonary Artery
27%
Randomized Clinical Trial
55%
Renin Angiotensin Aldosterone System
33%
Sodium Retention
37%
